Although advances in the management of multiple myeloma have improved survival, treatment in the relapsed or refractory setting remains challenging.

In this podcast Professor Paul Richardson and Professor Miles Prince talk through their considerations in the treatment of multiple myeloma and reflect on the differing perspectives that come from having a broader range of treatment options in the United States compared to what we have in Australia. 

 Professor Paul Richardson is Chair of the Alliance Myeloma Committee and Multiple Myeloma Research Consortium and Professor Miles Prince is the Chair of the Medical Scientific Advisory Group of Myeloma Australia.